Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
87 Leser
Artikel bewerten:
(0)

Texas Will Screen Newborns for SCID Beginning December 1

TOWSON, Md., Dec. 1, 2012 /PRNewswire/ -- The Texas Department of State Health Services (DSHS) will add Severe Combined Immunodeficiency (SCID) to the state's Newborn Screening Panel beginning December 1, 2012. The Immune Deficiency Foundation (IDF), the national patient organization for persons with primary immunodeficiency diseases, commends the state of Texas and the dedicated volunteers who have advocated for this cause. Screening for SCID increases the probability of early detection and treatment, potentially saving the lives of babies affected by the disease.

SCID is a primary immunodeficiency disease where affected infants lack T-lymphocytes, or white blood cells, that help fight infections from a wide array of viruses, bacteria and fungi, leaving these infants susceptible to serious, life-threatening infections. Babies with SCID appear healthy at birth, but without early treatment, most often by bone marrow transplant, these infants cannot survive. SCID infants who receive treatment within months of birth have a greater possibility of living happy, productive lives, thus the importance of newborn screening.

IDF continues to advocate for universal SCID newborn screening. Marcia Boyle, IDF President & Founder, said, "Implementing SCID newborn screening in Texas is a major milestone, and it is imperative that we sustain this momentum to establish newborn screening in all 50 states."

"The addition of SCID to the panel says to me that the individuals and groups CAN shape public policy through education, advocacy, and mobilization of interest groups," explained Texas resident and IDF volunteer Jennifer Garcia, mother of Cameron Garcia who died of SCID in March 2011. "It personally helps me feel some much needed peace in my heart, and that there was a purpose to Cameron's little life as well as the lives of all the other SCID angels."

Carol Ann Demaret, IDF Board member and mother of David Vetter (who was born with SCID and was known around the world as the "boy in the bubble") said, "When my beloved son, David, was born in 1971, it was only a dream that someday we would have this wonderful announcement. I am proud that David's home state of Texas will screen for SCID and give our children a greater chance at life. My prayer is to never again meet another family who has lost a child to SCID because diagnosis and treatment came too late. I congratulate the Texas DSHS and everyone who worked many years to guide this along."

About The Immune Deficiency Foundation

The Immune Deficiency Foundation (IDF), founded in 1980, is the national patient organization dedicated to improving the diagnosis, treatment and quality of life of persons with primary immunodeficiency diseases through advocacy, education and research.

To learn more about IDF, visit www.primaryimmune.org.

SOURCE Immune Deficiency Foundation

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.